377 related articles for article (PubMed ID: 28711472)
1. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
[TBL] [Abstract][Full Text] [Related]
2. The effects of glycine on auditory mismatch negativity in schizophrenia.
Greenwood LM; Leung S; Michie PT; Green A; Nathan PJ; Fitzgerald P; Johnston P; Solowij N; Kulkarni J; Croft RJ
Schizophr Res; 2018 Jan; 191():61-69. PubMed ID: 28602646
[TBL] [Abstract][Full Text] [Related]
3. Acute separate and combined effects of cannabinoid and nicotinic receptor agonists on MMN-indexed auditory deviance detection in healthy humans.
de la Salle S; Inyang L; Impey D; Smith D; Choueiry J; Nelson R; Heera J; Baddeley A; Ilivitsky V; Knott V
Pharmacol Biochem Behav; 2019 Sep; 184():172739. PubMed ID: 31283908
[TBL] [Abstract][Full Text] [Related]
4. Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans.
Mathalon DH; Ahn KH; Perry EB; Cho HS; Roach BJ; Blais RK; Bhakta S; Ranganathan M; Ford JM; D'Souza DC
Front Psychiatry; 2014; 5():3. PubMed ID: 24478731
[TBL] [Abstract][Full Text] [Related]
5. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.
Umbricht D; Koller R; Vollenweider FX; Schmid L
Biol Psychiatry; 2002 Mar; 51(5):400-6. PubMed ID: 11904134
[TBL] [Abstract][Full Text] [Related]
6. Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans.
Thiebes S; Leicht G; Curic S; Steinmann S; Polomac N; Andreou C; Eichler I; Eichler L; Zöllner C; Gallinat J; Hanganu-Opatz I; Mulert C
J Psychiatry Neurosci; 2017 Jun; 42(4):273-283. PubMed ID: 28556775
[TBL] [Abstract][Full Text] [Related]
7. Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms.
Kantrowitz JT; Epstein ML; Lee M; Lehrfeld N; Nolan KA; Shope C; Petkova E; Silipo G; Javitt DC
Schizophr Res; 2018 Jan; 191():70-79. PubMed ID: 28318835
[TBL] [Abstract][Full Text] [Related]
8. Nicotine effects on mismatch negativity in nonsmoking schizophrenic patients.
Inami R; Kirino E; Inoue R; Suzuki T; Arai H
Neuropsychobiology; 2007; 56(2-3):64-72. PubMed ID: 18037816
[TBL] [Abstract][Full Text] [Related]
9. Nicotine and the hallucinating brain: effects on mismatch negativity (MMN) in schizophrenia.
Fisher DJ; Grant B; Smith DM; Borracci G; Labelle A; Knott VJ
Psychiatry Res; 2012 Apr; 196(2-3):181-7. PubMed ID: 22425471
[TBL] [Abstract][Full Text] [Related]
10. Glutamatergic modulation of auditory information processing in the human brain.
Gunduz-Bruce H; Reinhart RM; Roach BJ; Gueorguieva R; Oliver S; D'Souza DC; Ford JM; Krystal JH; Mathalon DH
Biol Psychiatry; 2012 Jun; 71(11):969-77. PubMed ID: 22036036
[TBL] [Abstract][Full Text] [Related]
11. Modulation of auditory deviance detection by acute nicotine is baseline and deviant dependent in healthy nonsmokers: a mismatch negativity study.
Knott V; Impey D; Philippe T; Smith D; Choueiry J; de la Salle S; Dort H
Hum Psychopharmacol; 2014 Sep; 29(5):446-58. PubMed ID: 25196041
[TBL] [Abstract][Full Text] [Related]
12. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.
Lavoie S; Murray MM; Deppen P; Knyazeva MG; Berk M; Boulat O; Bovet P; Bush AI; Conus P; Copolov D; Fornari E; Meuli R; Solida A; Vianin P; Cuénod M; Buclin T; Do KQ
Neuropsychopharmacology; 2008 Aug; 33(9):2187-99. PubMed ID: 18004285
[TBL] [Abstract][Full Text] [Related]
13. Nicotine enhances automatic temporal processing as measured by the mismatch negativity waveform.
Martin LF; Davalos DB; Kisley MA
Nicotine Tob Res; 2009 Jun; 11(6):698-706. PubMed ID: 19436039
[TBL] [Abstract][Full Text] [Related]
14. Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects.
Leung S; Croft RJ; Baldeweg T; Nathan PJ
Psychopharmacology (Berl); 2007 Nov; 194(4):443-51. PubMed ID: 17611739
[TBL] [Abstract][Full Text] [Related]
15. Nicotine, Auditory Sensory Memory, and sustained Attention in a Human Ketamine Model of Schizophrenia: Moderating Influence of a Hallucinatory Trait.
Knott V; Shah D; Millar A; McIntosh J; Fisher D; Blais C; Ilivitsky V
Front Pharmacol; 2012; 3():172. PubMed ID: 23060793
[TBL] [Abstract][Full Text] [Related]
16. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
[TBL] [Abstract][Full Text] [Related]
17. The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.
Rosburg T; Kreitschmann-Andermahr I
Clin Neurophysiol; 2016 Feb; 127(2):1387-1394. PubMed ID: 26699665
[TBL] [Abstract][Full Text] [Related]
18. Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.
Knott VJ; Millar AM; McIntosh JF; Shah DK; Fisher DJ; Blais CM; Ilivitsky V; Horn E
Biol Psychol; 2011 Sep; 88(1):83-93. PubMed ID: 21742012
[TBL] [Abstract][Full Text] [Related]
19. Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice.
Ehrlichman RS; Maxwell CR; Majumdar S; Siegel SJ
J Cogn Neurosci; 2008 Aug; 20(8):1403-14. PubMed ID: 18303985
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
